SUMMARY Fourteen children with salt losing and five children with non-salt losing congenital adrenal hyperplasia were studied. Venous samples were collected for measurement of plasma renin activity, serum 17a-hydroxyprogesterone, testosterone, sodium, and creatinine. Overnight urinary sodium and creatinine excretions were measured after collection on an outpatient basis. Eight 'salt losers' had a raised plasma renin activity despite mineralocorticoid treatment, as did one 'non-salt loser'. Six of the children in whom clinical and biochemical control was inadequate, including the 'non-salt loser', had an increase in the dose of fludrocortisone. When the investigations were repeated one month later, a fall in plasma renin activity accompanied by a fall in 17a-hydroxyprogesterone in all but one patient were found. The dose of mineralocorticoid may be as critical as the dose of glucocorticoid in the management of congenital adrenal hyperplasia, and regular determination of plasma renin activity should be made, particularly if clinical control is difficult.
Cortisol, corticosterone, and aldosterone are synthesised from cholesterol by a series of enzymatically controlled steps. A deficiency of one of these enzymes, 21-hydroxylase, is the underlying cause in 90% of all cases of congenital adrenal hyperplasia. The resultant increase in androgen production will, if untreated, lead to virilisation. In children, Wilkins et al' introduced treatment with cortisone which was aimed at suppressing the production of the excessive androgens.
Up to 50% of these patients present in the first few weeks of life with a salt losing state that requires urgent mineralocorticoid and glucocorticoid replacement treatment. The adequacy of treatment is monitored by measuring urinary 17-oxosteroid and pregnanetriol excretion or more recently by the measurement of serum 17a-hydroxyprogesterone and testosterone; the latter being peripherally formed from adrenal androgens.2 Evaluation of sodium homeostasis also requires continued monitoring as it has been shown that despite adequate glucocorticoid replacement, satisfactory adrenal suppression may be difficult to achieve without adequate mineralocorticoid replacement in salt losing and non-salt losing patients.3 4
This study was designed to assess the value of measuring plasma renin activity in addition to 17a-hydroxyprogesterone and testosterone concentrations on an outpatient basis in the long term monitoring of children with congenital adrenal hyperplasia already on treatment with glucocorticoid and mineralocorticoid replacement, and to assess the effects of an alteration in the dosage of mineralocorticoid replacement where indicated.
Patients
Nineteen patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency were studied (Table 1) . Height was measured using a Harpenden stadiometer, pubertal development was assessed using the standards of Tanner and Whitehouse,5 and skeletal maturation by the system of Tanner, Whitehouse and Healey.6 Fourteen patients aged 3 to 16 years had an episode of salt loss in the neonatal period. All these children were being treated with glucocorticoid, 11 were taking cortisone, two hydrocortisone, and one prednisolone, given in equal divided dosage twice daily. All except one were also taking fludrocortisone in doses ranging from 25 [tg to 100 [sg/day. refused to give her daughter mineralocorticoid after renin activity measurement. At the same time blood the age of 1 year but she was being maintained on a was also collected for measurement of serum small dose of cortisone. Five children aged 5 to 14 17a-hydroxyprogesterone, testosterone, sodium, years had no history of salt loss. Of these, two girls and creatinine measurements. The blood collected presented with genital virilisation at birth and three for plasma renin activity measurement was kept cold boys had precocious puberty. These children were in an ice water bath, the plasma was separated on treatment with glucocorticoid, and one boy (case 4°C, and samples were stored frozen until assayed.
2) and one girl (case 6) were taking cyproterone In all patients blood was collected between 11.30 am acetate (50 mg to 100 mg twice daily) ( Table 2 ). and 12.15 pm. At the time of investigation all the children were well and were receiving a sodium intake of greater Methods than 100 mmol/day. They were all seen in a children's day ward after having had their morning Serum 17a-hydroxyprogesterone was measured by doses of steroid and usual breakfast at home. Each radioimmunoassay, essentially as described by child collected an overnight, timed sample of Davila et al.7 The immunogen used to raise the urine for measurement of sodium and creatinine antibody in rabbits was a 17a-hydroxyprogesexcretion. After resting in the supine position for terone-3-(0-carboxymethyl) oxime bovine serum two hours, blood obtained by venepuncture was albumin conjugate. Slight modifications to the transferred to tubes containing disodium ethylene-method were the use of an antibody with reduced diamenetetra-acetic acid (1-2 mg/ml) for plasma cross reactivity for progesterone (less than 1-0%) Plasma renin activity was determined using a kit (Angiotensin I radio-immunoassay kit, CIS UK) which measured the angiotensin I generated when plasma was incubated at 37°C in the presence of inhibitors of converting enzyme (which converts angiotensin I to angiotensin II) and angiotensinases. Single end point determinations may give falsely low values in cases of substrate exhaustion and so angiotensin I was routinely measured in aliquots of the incubation mixture at regular timed intervals. Plasma renin activity was also measured under identical conditions and at the same time of day in four healthy children with no evidence of renal or endocrine abnormality.
The adequacy of previous steroid dosage was assessed by reviewing clinical records of growth, bone age, and sexual development over the previous two years. Using these criteria 9 children were considered to be well controlled and 7 under treated. Treatment could not be fully assessed in three boys with pubertal testicular development.
Eleven children were recalled and the investigations repeated under identical conditions without change in steroid treatment. In five children with a history of early salt loss and an appreciably raised plasma renin activity8 of greater than 5 nmol/l/hour on two occasions, the dose of fludrocortisone was increased by 50 rg/day. One prepubertal girl with no history of salt loss but a raised plasma renin activity and clinical evidence of inadequate treatment, was started on 50 [tg/day of fludrocortisone. Investigations in the six children whose dose of fludrocortisone had been increased were repeated three or four weeks later.
Results
Serum sodium concentrations were within the reference interval 134 to 145 mmol/l in 17 of the 19 patients ( Table 1) . The one child whose mother had refused treatment with mineralocorticoid had a serum sodium value of 125 mmol/l and another who had been vomiting the day before had a value of 133 mmol/l. Urinary sodium excretion, as might have been expected because of the high dietary salt intake, was increased above the reference interval of 0-08 to 0-16 mmol/kg body weight in all children studied except one, for whom urine collection was incomplete, and there was no statistical difference between 'salt losers' and 'non-salt losers' (P<0-4). In four of the 6 children in whom the dose of fludrocortisone was increased a fall in sodium occurred, with a slight increase in the remaining two. Creatinine clearance was within reference intervals for 15 of the children studied,9 in three children the urine collections were incomplete, and in one patient (case 9) we have no adequate explanation for reduced clearance.
Plasma renin activity in four apparently healthy children aged 8 to 16 years with no evidence of renal or endocrine disease, was 1-3, 2-4, 2-7, and 3-5 nmoll/lhour. The results in the congenital adrenal hyperplasia patients are shown in Table 1 and graphically depicted in Fig. 1 . Nine of the children with congenital adrenal hyperplasia had plasma renin activity values of greater than 5*0 nmol/l/hour and only one of these was a 'non-salt loser'. Plasma renin activity in the 'salt losers' ranged from 0-5 to 27-8 (mean 10O9)nmol/l/hour. After increasing the dose of fludrocortisone in the 6 children there was a statisticallv significant drop in plasma renin activity (P<0-02) in all including the one child who had no early history of salt loss (Fig. 2) 16-0 nmol/l) . Of the other 9 children, 7 were considered to be well controlled by clinical assessment. In 7 children showing no pubertal development, serum testosterone ranged from 1-0 to 15-0 nmol/l (mean 3-7 nmoLl1). Serum testosterone concentrations when compared with 17a-hydroxyprogesterone showed a correlation only for the prepubertal children (n=9, r=0-943, P=0-05 to 0.02). Increasing the dose of fludrocortisone had no consistent effect on serum testosterone.
Blood pressure in all children studied was normal at all times, and there was no alteration in salt appetite. 
